Pharmacogenomics logo Future Medicine logo

Pharmacogenomics provides the community with an essential resource for keeping abreast of the latest developments in new pharmacogenomic initiatives, emerging technologies for accessing genomic information and the development of novel diagnostic products and strategies.

Publisher: Future Medicine

Volume 8, Number 5, May 2007
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Editorial

Nutrigenomics in perspective
pp. 421-424(4)
Author: Mariman, E C M

Future of toxicogenomics and safety signatures: balancing public access to data with proprietary drug discovery
pp. 425-430(6)
Author: Fostel, Jennifer M

Bulletin Board

Is time running out for bipolar disorder?
pp. 431-433(3)

Research Report

Glutathione S-transferase M1 null genotype as a risk factor for carbamazepine-induced mild hepatotoxicity
pp. 435-442(8)
Authors: Ueda, Kentaro; Ishitsu, Takateru; Seo, Takayuki; Ueda, Nao; Murata, Tsukasa; Hori, Masaharu; Nakagawa, Kazuko

Sex-dependent genetic markers of CYP3A4 expression and activity in human liver microsomes
pp. 443-453(11)
Authors: Schirmer, Markus; Rosenberger, Albert; Klein, Kathrin; Kulle, Bettina; Toliat, Mohammad R; Nürnberg, Peter; Zanger, Ulrich M; Wojnowski, Leszek

Review

Genetic association meets RNA interference: large-scale genomic screens for causation and mechanism of complex diseases
pp. 455-464(10)
Authors: Martin, Mitchell; Reidhaar-Olson, John F; Rondinone, Cristina M

Adducin polymorphisms and the treatment of hypertension
pp. 465-472(8)
Authors: Manunta, Paolo; Citterio, Lorena; Lanzani, Chiara; Ferrandi, Mara

Key aspects of analyzing microarray gene-expression data
pp. 473-482(10)
Author: Chen, James J

Perspective

Gene therapy to fight infection in skin transplants
pp. 483-486(4)
Author: Supp, Dorothy M

Special Report

Identifying the genotype behind the phenotype: a role model found in VKORC1 and its association with warfarin dosing
pp. 487-496(10)
Authors: Crawford, Dana C; Ritchie, Marylyn D; Rieder, Mark J

Pharmacogenetics and stomach cancer: an update
pp. 497-505(9)
Authors: Toffoli, Giuseppe; Cecchin, Erika

How can the emerging patient-centric health records lower costs in pharmacogenomics?
pp. 507-511(5)
Author: Shabo Shvo, Amnon

Priority Paper Evaluation

Effects of dopamine D2 receptor gene polymorphisms on smoking cessation: abstinence and withdrawal symptoms
pp. 513-517(5)
Authors: Munafò, Marcus R; Johnstone, Elaine C

Commentary

Genetic nondiscrimination legislation: a critical prerequisite for pharmacogenomics data sharing
pp. 519-519(1)
Authors: Altman, Russ B; Benowitz, Neal; Gurwitz, David; Lunshof, Jeantine; Relling, Mary; Lamba, Jatinder; Wieben, Eric; Mooney, Sean; Giacomini, Kathleen; Weiss, Scott; Johnson, Julie A; McLeod, Howard; Flockhart, David; Weinshilboum, Richard; Shuldiner, Alan R; Roden, Dan; Krauss, Ronald M; Ratain, Mark

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A